Table 2.

Prevalence of AF in AL and TTR amyloidosis in most recent studies

Study, date	Population	Overall prevalence	Prevalence in TTR	Prevalence in AL
Longhi et al., 2015 20	N = 262
	123 AL, 94 hTTR, 45 wtTTR	15%	35%	9%
Mints et al., 2018 23	N = 146 wtTTR	70%	70%	—
Sanchis et al., 2019 19	N = 238, 115 AL, 97 wtTTR, 26 hTTR	44%	60%	26%
Martinez‐Naharro et al., 2019 18	N = 324, 166 TTR, 155 AL		46%	14%
Mitrani et al., 2020 21	N = 290 TTR	75%	75%	—
Donellan et al., 2020 22	N = 265, 205 wt, 60 vTTR	69%	69%	—

AL, immunoglobulin light chain amyloidosis; TTR, transthyretin; vTTR, variant transthyretin; wTTR: wild type transthyretin.